Connecting you to content on EBSCOhost

Works by Knoblauch, Roland E.

Results: 3

1

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.

Published in:

2019

By:

Jones, Robin L.;
Maki, Robert G.;
Patel, Shreyaskumar R.;
Wang, George;
McGowan, Tracy A.;
Shalaby, Waleed S.;
Knoblauch, Roland E.;
von Mehren, Margaret;
Demetri, George D.

Publication type:

journal article

2

Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial.

Published in:

Investigational New Drugs, 2018, v. 36, n. 3, p. 476, doi. 10.1007/s10637-017-0546-9

By:

Calvo, Emiliano;
Azaro, Analia;
Rodon, Jordi;
Dirix, Luc;
Huizing, Manon;
Senecal, Francis Mark;
LoRusso, Patricia;
Yee, Lorrin;
Poggesi, Italo;
de Jong, Jan;
Triantos, Spyros;
Park, Youn C.;
Knoblauch, Roland E.;
Parekh, Trilok V.;
Demetri, George D.;
von Mehren, Margaret

Publication type:

Article

3

Determination and Confirmation of Recommended Ph2 Dose of Amivantamab in Epidermal Growth Factor Receptor Exon 20 Insertion Non‐Small Cell Lung Cancer.

Published in:

Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 468, doi. 10.1002/cpt.3064

By:

Haddish‐Berhane, Nahor;
Su, Yaming;
Russu, Alberto;
Thayu, Meena;
Knoblauch, Roland E.;
Mehta, Jaydeep;
Xie, John;
Gibbs, Eric;
Sun, Yu‐Nien;
Zhou, Honghui

Publication type:

Article